Celldex Therapeutics, Inc.
CLDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000744218
No open-market purchases or sales by Celldex Therapeutics, Inc. insiders were filed in the last 90 days; 253 institutions reported holding it in 13F filings for Q2 2026, worth $3.19B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Celldex Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Celldex Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Penner Harry Jr | Director | – | Jun 29, 2026 | 1 |
| Marino James J | Director | 2,204 | Jun 29, 2026 | 1 |
| Pepin Ronald | SR. VP & CBO | 20,097 | Jun 29, 2026 | 2 |
| Conrad Herbert J | Director | – | Jun 29, 2026 | 1 |
| Keler Tibor | EXECUTIVE VP & CSO | 7,357 | Jun 29, 2026 | 1 |
| Marucci Anthony S | PRESIDENT & CEO | 40,284 | Jun 29, 2026 | 1 |
| Brownlie Keith L | Director | – | Jun 29, 2026 | 1 |
| Cohen Cheryl | Director | – | Jun 29, 2026 | 1 |
| Neil Garry Arthur | Director | – | Jun 29, 2026 | 1 |
| Young Diane C. | SVP, CHIEF MEDICAL OFFICER | 17,115 | Jun 29, 2026 | 1 |
| Crowley Elizabeth | SR. VP & CPDO | 9,074 | Jun 29, 2026 | 1 |
| Jain Rita | Director | – | Jun 29, 2026 | 1 |
| Martin Samuel Bates | SVP AND CFO | 32,942 | Jun 29, 2026 | 2 |
| Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | 1,860 | Jun 29, 2026 | 1 |
| Heath-Chiozzi Margo | SVP OF REGULATORY AFFAIRS | 13,383 | Jun 29, 2026 | 1 |
| Torres Denice | Director | – | Jun 29, 2026 | 1 |
| Jimenez Freddy A. | SVP & GENERAL COUNSEL | 30,796 | Jun 29, 2026 | 2 |
| Lawver Teri L | SVP & Chief Commercial Officer | – | Jun 29, 2026 | 2 |
| Wright Richard M. | Other: Former Officer | 20,833 | Nov 17, 2025 | 1 |
| Shoos Karen L. | Director | – | Jun 17, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 (view filing) | Dec 4 | 4 days | Jimenez Freddy A.SVP & GENERAL COUNSEL | SSale | −4.17K | $29.10 | −$121.2K | −11.9%30.8K after | |
| Nov 17, 2025 (view filing) | Nov 13 | 4 days | Wright Richard M.Other: Former Officer | SSale | −49.3K | $24.00 | −$1.18M | −70.3%20.8K after | |
| Aug 15, 2025 (view filing) | Aug 13 | 2 days | Jimenez Freddy A.SVP & GENERAL COUNSEL | SSale | −771 | $24.77 | −$19.1K | −2.2%35.0K after | 2 lots |
| Nov 12, 2024 (view filing) | Nov 11 | 1 day | Marucci Anthony SPRESIDENT & CEO | PPurchase | +11.5K | $26.82 | +$308.4K | +40.0%40.3K after | |
| Jun 18, 2024 (view filing) | Jun 14 | 4 days | Martin Samuel BatesSVP AND CFO | SSale | −17.2K | $35.42 | −$608.2K | −37.9%28.1K after | |
| Jun 18, 2024 (view filing) | Jun 14 | 4 days | Crowley ElizabethSR. VP & CPDO | SSale | −30.0K | $34.87 | −$1.05M | −76.8%9.07K after | |
| Jun 11, 2024 (view filing) | Jun 7 | 4 days | Crowley ElizabethSR. VP & CPDO | SSale | −15.0K | $35.06 | −$525.9K | −62.3%9.07K after | |
| Jun 11, 2024 (view filing) | Jun 7 | 4 days | Young Diane C.SVP, CHIEF MEDICAL OFFICER | SSale | −45.0K | $35.26 | −$1.59M | −95.5%2.12K after | |
| Jun 5, 2024 (view filing) | Jun 3 | 2 days | Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS | SSale | −58.4K | $33.65 | −$1.96M | −81.3%13.4K after | |
| Jun 5, 2024 (view filing) | Jun 3 | 2 days | Wright Richard M.SR. VP & CCO | SSale | −46.8K | $33.72 | −$1.58M | −69.2%20.8K after | 2 lots |
| Jun 5, 2024 (view filing) | Jun 3 | 2 days | Jimenez Freddy A.SVP & GENERAL COUNSEL | SSale | −8.01K | $33.60 | −$269.0K | −23.6%25.9K after | |
| Jun 3, 2024 (view filing) | May 30 | 4 days | Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS | SSale | −38.7K | $34.07 | −$1.32M | −84.5%7.09K after | |
| Jun 3, 2024 (view filing) | May 30 | 4 days | Martin Samuel BatesSVP AND CFO | SSale | −35.0K | $34.05 | −$1.19M | −58.2%25.1K after | |
| Jun 3, 2024 (view filing) | May 30 | 4 days | Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN. | SSale | −20.9K | $33.73 | −$703.4K | −91.8%1.86K after | |
| Jun 3, 2024 (view filing) | May 30 | 4 days | Crowley ElizabethSR. VP & CPDO | SSale | −38.6K | $33.64 | −$1.30M | −81.0%9.07K after | |
| Dec 9, 2022 (view filing) | Dec 7 | 2 days | Keler TiborEXECUTIVE VP & CSO | SSaleCommon Stock, par value $0.001 per share | −16.9K | $36.93 | −$622.6K | −69.6%7.36K after | |
| Aug 19, 2022 (view filing) | Aug 17-18 | 2 days | Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN. | SSale | −32.7K | $36.72 | −$1.20M | −96.2%1.28K after | 2 lots |
| Aug 19, 2022 (view filing) | Aug 17 | 2 days | Young Diane C.SVP, CHIEF MEDICAL OFFICER | SSale | −19.0K | $37.30 | −$708.7K | −90.0%2.12K after | |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Marucci Anthony SPRESIDENT & CEO | SSale | −120.0K | $37.66 | −$4.52M | −81.3%27.7K after | |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Wright Richard M.SR. VP & CCO | SSale | −15.3K | $37.71 | −$578.0K | −98.7%208 after | |
| Aug 15, 2022 (view filing) | Aug 11-12 | 4 days | Martin Samuel BatesSVP AND CFO | SSale | −20.0K | $36.52 | −$730.4K | −45.1%24.4K after | 4 lots |
| Dec 28, 2021 (view filing) | Dec 23 | 5 days | Martin Samuel BatesSVP and CFO | SSale | −9.50K | $42.00 | −$399.0K | −28.0%24.4K after | |
| Dec 10, 2021 (view filing) | Dec 8 | 2 days | Cavanaugh SarahSVP of Corp Affairs & Admin. | SSale | −7.32K | $40.00 | −$292.9K | −94.7%408 after | |
| Dec 10, 2021 (view filing) | Dec 8 | 2 days | Crowley ElizabethSr. VP &CPDO | SSale | −4.00K | $40.00 | −$160.0K | −45.8%4.73K after | |
| Dec 10, 2021 (view filing) | Dec 8 | 2 days | Heath-Chiozzi MargoSVP of Regulatory Affairs | SSale | −600 | $40.00 | −$24.0K | −5.1%11.2K after | |
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Martin Samuel BatesSVP and CFO | SSale | −9.50K | $43.56 | −$413.9K | −26.1%26.9K after | 2 lots |
| Nov 16, 2021 (view filing) | Nov 12 | 4 days | Young Diane C.SVP, Chief Medical Officer | SSale | −4.60K | $42.94 | −$197.5K | −68.5%2.12K after | |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Cavanaugh SarahSVP of Corp Affairs & Admin. | SSale | −7.32K | $43.26 | −$316.8K | −94.7%408 after | 3 lots |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Crowley ElizabethSr. VP &CPDO | SSale | −4.32K | $43.29 | −$186.9K | −47.7%4.73K after | 3 lots |
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Heath-Chiozzi MargoSVP of Regulatory Affairs | SSale | −600 | $41.71 | −$25.0K | −5.1%11.2K after | |
| Aug 13, 2021 (view filing) | Aug 11 | 2 days | Jimenez Freddy A.SVP & General Counsel | PPurchase | +430 | $46.28 | +$19.9K | New position430 after | |
| Aug 12, 2021 (view filing) | Aug 10 | 2 days | Martin Samuel BatesSVP and CFO | SSale | −2.74K | $45.25 | −$123.9K | −8.5%29.4K after | 2 lots |